Celcuity (CELC) Non-Current Debt (2021 - 2025)
Celcuity (CELC) posted Non-Current Debt of $126.5 million for Q4 2025, up 1.09% on a QoQ basis from $125.2 million in Q3 2025, and up 29.47% year-over-year from $97.7 million in Q4 2024.
Celcuity (CELC) Non-Current Debt (2021 - 2025) Analysis & Trends
Celcuity's Non-Current Debt history runs 5 years deep, the most recent figure standing at $126.5 million for Q4 2025.
- Quarterly Non-Current Debt rose 29.47% year-over-year to $126.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $126.5 million (up 29.47% YoY) and the FY2025 annual result came in at $126.5 million, up 29.47% from the prior year.
- Non-Current Debt was $126.5 million for Q4 2025 at Celcuity, up from $125.2 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $126.5 million in Q4 2025 and bottomed at $14.2 million in Q2 2021.
- A 5-year average of $55.1 million and a median of $36.5 million in 2023 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2024 — Non-Current Debt surged 167.31% — and 2025, when it increased 3.2%.
- Celcuity's Non-Current Debt stood at $14.6 million in 2021, then soared by 139.19% to $35.0 million in 2022, then gained by 5.87% to $37.0 million in 2023, then surged by 163.87% to $97.7 million in 2024, then gained by 29.47% to $126.5 million in 2025.
- Business Quant data shows CELC's Non-Current Debt at $126.5 million in Q4 2025, $125.2 million in Q3 2025, and $99.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | 126.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 126.53 Mn |
| Sep 30, 2025 | 125.17 Mn |
| Jun 30, 2025 | 99.28 Mn |
| Mar 31, 2025 | 98.53 Mn |
| Dec 31, 2024 | 97.73 Mn |
| Sep 30, 2024 | 96.92 Mn |
| Jun 30, 2024 | 96.19 Mn |
| Mar 31, 2024 | 37.57 Mn |
| Dec 31, 2023 | 37.04 Mn |
| Sep 30, 2023 | 36.51 Mn |
| Jun 30, 2023 | 35.99 Mn |
| Mar 31, 2023 | 35.48 Mn |
| Dec 31, 2022 | 34.98 Mn |
| Sep 30, 2022 | 15.01 Mn |
| Jun 30, 2022 | 15.01 Mn |
| Mar 31, 2022 | 14.82 Mn |
| Dec 31, 2021 | 14.63 Mn |
| Sep 30, 2021 | 14.43 Mn |
| Jun 30, 2021 | 14.23 Mn |